IGFBP2 and neoplasm: Genomic drivers leading to glioblastoma metastasis are not fully understood, but mutations in TP53, IGFBP2, BRACA1, ARID1A, SMARCB1 and matrix metalloproteinase have been associated with tumor progression and dissemination.